|
|
||||||||
Departments of 1 Medicine and 3 Surgery, University of Wisconsin, and the 2 William S. Middleton Veterans Hospital, Madison, Wisconsin 53705
| |
ABSTRACT |
|---|
|
|
|---|
We examined the neurocirculatory and ventilatory responses to intermittent asphyxia (arterial O2 saturation = 79-85%, end-tidal PCO2 =3-5 Torr above eupnea) in seven healthy humans during wakefulness. The intermittent asphyxia intervention consisted of 20-s asphyxic exposures alternating with 40-s periods of room-air breathing for a total of 20 min. Minute ventilation increased during the intermittent asphyxia period (14.2 ± 2.0 l/min in the final 5 min of asphyxia vs. 7.5 ± 0.4 l/min in baseline) but returned to the baseline level within 2 min after completion of the series of asphyxic exposures. Muscle sympathetic nerve activity increased progressively, reaching 175 ± 12% of baseline in the final 5 min of the intervention. Unlike ventilation, sympathetic activity remained elevated for at least 20 min after removal of the chemical stimuli (150 ± 10% of baseline in the last 5 min of the recovery period). Intermittent asphyxia caused a small, but statistically significant, increase in heart rate (64 ± 4 beats/min in the final 5 min of asphyxia vs. 61 ± 4 beats/min in baseline); however, this increase was not sustained after the return to room-air breathing. These data demonstrate that relatively short-term exposure to intermittent asphyxia causes sympathetic activation that persists after removal of the chemical stimuli. This carryover effect provides a potential mechanism whereby intermittent asphyxia during sleep could lead to chronic sympathetic activation in patients with sleep apnea syndrome.
sympathetic nervous system; hypoxia; hypercapnia
| |
INTRODUCTION |
|---|
|
|
|---|
OUR LABORATORY HAS PREVIOUSLY demonstrated that a 20-min steady-state exposure to asphyxia (hypoxia plus hypercapnia) during wakefulness causes marked sympathetic activation that persists after withdrawal of the chemical stimuli (14). This carryover effect may explain the chronic sympathoexcitation observed in patients with sleep-disordered breathing (6); however, our experimental paradigm failed to mimic this clinical entity in at least one important way. Sleep-disordered breathing is characterized by discrete apneas and hypopneas that produce intermittent, rather than sustained, periods of asphyxia.
Because the sympathetic nervous system response to hypoxia is dependent on both the severity and duration of exposure (18), one might predict that intermittent asphyxia would cause less intense sympathetic activation than would steady-state asphyxia. On the other hand, steady-state changes may be less potent than frequent oscillations in stimulating the carotid body, an organ with high dynamic sensitivity to fluctuations in arterial blood-gas tensions (16). The purpose of this experiment was to study the neurocirculatory and ventilatory responses to a 20-min period of intermittent asphyxia in healthy human subjects during wakefulness.
| |
METHODS |
|---|
|
|
|---|
Subjects
Seven healthy male volunteers with a mean age of 36 yr (range 27-44 yr) served as subjects. All were free of cardiovascular, pulmonary, and neurological diseases. They were also nonsmokers and were receiving no medication. This study was approved by the University of Wisconsin Health Sciences Human Subjects Committee and the Middleton Memorial Veterans Hospital Human Research Review Committee.General Procedures
Subjects were studied in the supine position. Room temperature was maintained at 24 ± 1°C. During the experiments, respiratory and cardiovascular variables and sympathetic nerve traffic were measured. All tracings were recorded continuously on paper (Gould, Cleveland, OH) and on magnetic tape (Vetter, Rebersburg, PA).Respiratory variables.
Tidal volume and breathing frequency were monitored with a
pneumotachograph (model 5719; Hans Rudolph, Kansas City, MO) attached to a leak-free nasal mask. Minute ventilation (
E)
was calculated by multiplying tidal volume by breathing frequency.
End-tidal oxygen (PETO2) and carbon
dioxide (PETCO2) tensions were measured by
using LB-2 and OM-11 analyzers (Beckman, Schiller Park, IL). Arterial
oxygen saturation (SaO2) was measured by using a pulse oximeter probe placed on the right ear lobe (Biox 3740; Ohmeda, Madison, WI).
Cardiovascular variables. Heart rate was taken from the electrocardiogram. Arterial pressure was measured at 1-min intervals by using an automated arm-cuff sphygmomanometer (Dinamap; Critikon, Tampa, FL) and also beat by beat by using finger pulse photoplethysmography (Finapres; Ohmeda, Englewood, CO). The finger bearing the photoplethysmograph cuff was positioned at heart level and kept at the same level for the duration of the study.
Sympathetic nerve activity. Postganglionic muscle sympathetic nerve activity in the right peroneal nerve was recorded directly by using the microneurography technique (22). The neural signals were passed to a differential preamplifier, an amplifier (total gain = 100,000), a band-pass filter (700-2,000 Hz), and an integrator (time constant = 100 ms). Placement of the recording electrode within a muscle nerve fascicle was confirmed by 1) the presence of muscle twitches, but not paresthesias, in response to electrical stimulation; 2) the pulse synchronous nature of the nerve activity; 3) the appearance of afferent activity in response to tapping or stretching of muscle, but not gentle stroking of skin, in the appropriate receptive fields; and 4) the absence of neural activation in response to a startle stimulus. Once an acceptable neural recording (pulse synchronous activity with signal-to-noise ratio >3:1) was obtained, the subject was instructed to maintain the leg in a relaxed position for the duration of the study. Sympathetic bursts were identified by inspection of the mean voltage neurogram (25). For purposes of quantification, muscle sympathetic nerve activity was expressed as burst frequency (bursts/min), burst amplitude (arbitrary units), and total minute activity (burst frequency times mean burst amplitude in arbitrary units). Changes in all measures of muscle sympathetic nerve activity during the intervention and recovery periods were expressed as a percentage of the baseline level.
Experimental Protocols
After stable baseline measurements of neurocirculatory and ventilatory variables were obtained (at least 5 min), the subject was exposed to a series of repetitive asphyxic challenges that were administered by nasal mask. Nitrogen (95%) was added to the breathing circuit for two to three breaths to quickly lower SaO2. Then, for the remainder of the 20-s asphyxia phase, the nitrogen and carbon dioxide concentrations were adjusted to produce a lowering of SaO2 to 80% and a rise in PETCO2 of +3-5 Torr. For the remaining 40 s of each minute, the subject breathed room air. This intermittent asphyxia cycle was repeated 20 times. The 20-min exposure to intermittent asphyxia was immediately followed by a 20-min recovery period of room-air breathing. In three of the present subjects, time control experiments were performed as part of a previous study (14). In these experiments, the subjects breathed room air through the nasal mask for 40 min.Data Analysis
To examine the overall response to intermittent asphyxia, 5-min averages of neurocirculatory and ventilatory variables obtained during the baseline, intermittent asphyxia, and recovery periods were compared by one-way ANOVA with repeated measures. Five-minute averages of these variables during time control experiments were compared in the same manner. When overall F tests were statistically significant (P < 0.05), Dunnett's post hoc tests were used to compare measurements made during the intermittent asphyxia and recovery periods with the baseline period means.To examine phasic responses to the oscillating chemical stimuli, we
subdivided the intermittent asphyxia cycles into phases according to
PETO2.
The asphyxia phases (e.g., the period between the dashed lines in Fig.
1) began at the end of inspiration of the
first hypoxic breath and ended at the end of inspiration of the first
room-air breath of each cycle. The interasphyxia phases were defined as
the periods of time between two consecutive asphyxia phases. To examine
the time course of the phasic neurocirculatory responses over the 20 min of intermittent asphyxia exposure, we performed least squares
regression analyses of time vs.
E and sympathetic
nerve activity in both the asphyxia and interasphyxia phases. Analysis
of variance of regression was used to determine whether the slopes of
the regression lines were statistically different from zero.
|
| |
RESULTS |
|---|
|
|
|---|
Chemical Stimuli During Intermittent Asphyxia
A polygraph record illustrating the oscillating chemical stimuli and resultant physiological responses in one representative subject is shown in Fig. 1. During each minute of the intermittent asphyxia period, the subjects spent an average of 21 ± 2 s breathing the asphyxic gas mixture and 39 ± 2 s breathing room air. The nadir values for SaO2 averaged 82 ± 1% during the asphyxia phases with 7 ± 2 s of each minute spent at SaO2 <85%. In the recovery period, average values for PETCO2 and PETO2 were the same as those for the baseline levels (38 ± 1 vs. 39 ± 2 and 113 ± 2 vs. 110 ± 3 Torr, respectively).Ventilatory Response to Intermittent Asphyxia
Throughout the 20-min intermittent asphyxia period,
E was elevated relative to baseline levels (Figs. 1
and 2A). In contrast,
E did not change in time control experiments
conducted in three of the seven subjects (Fig. 2A). During
asphyxia-interasphyxia cycles, phasic oscillations in
E were observed (Figs. 1 and 3A). The
E
during the asphyxia phases increased over time as shown by a positive
slope that was statistically different from zero (slope = +0.10 ± 0.04 l · min
1 · min
1;
P = 0.03; Fig. 3A). In contrast, no
progressive increase in
E was noted during the
interasphyxia phases (slope = +0.04 ± 0.04 l · min
1 · min
1;
P = 0.24). Slopes and regression coefficients for
individual subjects are shown in Table 1.
During the recovery period,
E returned to the
baseline level within 2 min after return to room-air breathing.
|
|
|
Effects of Intermittent Asphyxia on Muscle Sympathetic Nerve Activity
Total minute activity rose progressively during the intermittent asphyxia period so that in the final 5 min of the intervention, muscle sympathetic nerve activity had risen to 175 ± 12% of the baseline level (Figs. 1 and 2B). This response resulted from increases in both the frequency (141 ± 12% of baseline) and amplitude (127 ± 8% of baseline) of sympathetic bursts. Furthermore, total minute activity remained elevated (150 ± 10% of baseline) at the end of the 20-min recovery period of room-air breathing even though PETO2, PETCO2, and
E returned
to baseline levels (Figs. 1 and 2B). In contrast, total
minute activity remained stable during time control experiments (Fig.
2B).
A closer look at sympathetic activation during the intermittent asphyxia period reveals two major features (Fig. 3B). First, muscle sympathetic nerve activity oscillated during the asphyxia-interasphyxia cycles. Second, total minute activity during successive interasphyxia phases increased progressively during the 20-min exposure period, as shown by a slope that was statistically different from zero (slope = +2.98 ± 0.42% of baseline/min; P < 0.001; Fig. 3B). In contrast, we did not observe a time-dependent increase in total minute activity during the asphyxia phases (slope = +0.36 ± 0.64% of baseline/min; P = 0.58). Slopes and regression coefficients for individual subjects are shown in Table 1.
Cardiovascular Response to Intermittent Asphyxia
Compared with the baseline period, intermittent asphyxia caused a transient increase in systolic pressure but no change in diastolic pressure (Fig. 4A). During the asphyxia-interasphyxia cycles, systolic and diastolic pressures fluctuated above and below the control value, ascending during the asphyxia and descending during the interasphyxia phases (Fig. 1). Heart rates were higher during the intermittent asphyxia exposure than in the baseline period (Fig. 4B). The increases in systolic pressure and heart rate produced by intermittent asphyxia did not persist in the postintervention recovery period.
|
| |
DISCUSSION |
|---|
|
|
|---|
The major findings of this study are twofold. First, brief
intermittent exposure to asphyxia caused a substantial, progressive increase in sympathetic outflow to skeletal muscle. Second, a statistically significant portion of this asphyxia-induced sympathetic activation persisted even after reestablishment of normoxic and normocapnic conditions and the normalization of
E.
The results of this study confirm our previous findings of sustained
sympathetic activation caused by steady-state exposure to asphyxia
(14) and extend them by demonstrating that a carryover
effect also occurs when the asphyxic stimulus is presented in
intermittent fashion.
Critique of Methods
The possibilities that sympathetic outflow increased spontaneously or that the position of the intraneural electrode was not stable over time threaten the validity of our conclusion that intermittent asphyxia caused sustained sympathoexcitation. The former possibility is unlikely because sympathetic nerve activity remained stable during 40 min of room-air breathing in time control experiments. We also consider it unlikely that electrode instability affected our data. Shifts in the position of the electrode within the nerve fascicle produce easily detectable offsets in the baseline of the mean voltage neurogram; we excluded from analysis experiments in which such offsets were detected.In addition, we recorded sympathetic discharge that is targeted to vascular structures in leg muscle. This discharge is representative of sympathetic outflow to skeletal muscle vascular beds throughout the body (17); however, we cannot extrapolate our findings to other organs or vascular beds.
Sympathetic Neural Response to Intermittent Asphyxia
The stimulant effects of hypoxia and hypercapnia on sympathetic activity are well known (19-21). However, we are aware of only one previous study, conducted in anesthetized cats, that demonstrated a carryover of the sympathoexcitatory effects of hypoxia beyond the exposure period (10). Although the authors did not comment on this aftereffect, several of their figures indicate that 1-10 min of hypoxic exposure caused a significant increase in sympathetic outflow to hindlimb muscle that persisted for several minutes beyond the period of chemical stimulation (10).The present findings in human subjects indicate that sustained sympathetic activation occurs after a relatively brief (20-min) exposure to intermittent asphyxia. Compared with the steady-state asphyxia intervention utilized in our laboratory's previous study (14), intermittent asphyxia in the present experiments caused a smaller elevation of sympathetic outflow (175% of baseline level after 20 min of intermittent asphyxia vs. 220% of baseline level after 20 min of steady-state asphyxia). Nevertheless, the carryover effect on muscle sympathetic activity was comparable with the two interventions. This finding is remarkable because the overall duration of chemoreflex stimulation was shorter in the present study (SaO2 was <85% for 12% of the time during intermittent asphyxia vs. 100% of the time during sustained asphyxia). These findings suggest that intermittent and sustained exposures to asphyxia are equally effective in eliciting a poststimulus elevation in muscle sympathetic nerve activity.
A carryover effect on muscle sympathetic nerve activity was also observed within the intermittent asphyxia cycles, i.e., in the interasphyxia phases when the subjects breathed room air. Muscle sympathetic nerve activity did not return to baseline levels in these brief "recovery" periods between successive asphyxic exposures. In fact, the amount of sympathetic activation present in the interasphyxia phases progressively increased throughout the 20-min intervention period. This finding suggests that asphyxic exposures shorter than 20 min may also induce sympathetic activation that outlasts the chemical stimuli. However, even though PETO2 and PETCO2 indicated normalization of blood chemistry in the interasphyxia phases, we cannot rule out the possibility of persistent acidosis in chemosensitive areas of the brain (see below).
Mechanism of Sympathetic Neural Response to Intermittent Asphyxia
Our laboratory has previously hypothesized that asphyxic exposure may produce a facilitatory memory within the central nervous system that requires input from central and/or peripheral chemoreceptors (14). This facilitatory memory may result from enhanced synaptic efficacy (1) and/or persistent increases in concentrations of excitatory neurotransmitters within central nervous system regions that regulate sympathetic outflow. The slowly disappearing postasphyxic effect on sympathetic outflow is analogous to the long-term facilitation that maintains ventilation or phrenic activity above baseline levels for >1 h after episodic carotid sinus nerve stimulation (11, 13). However, the mechanism underlying the observed effect on sympathetic outflow is not identical to that responsible for long-term facilitation of
E,
because
E had returned to baseline levels within 2 min after exposure. In contrast to the progressive buildup of
sympathetic activity we observed in the interasphyxia phases, there was
no concomitant progressive rise in
E. These latter
findings are both consistent with short- rather than long-term
facilitation of
E (4).
Persistent increases in chemical stimuli in arterial blood or in brain
extracellular fluid might explain the persistent elevation in
sympathetic nerve activity we observed, but we believe this is unlikely
for two reasons. First, our data show that
PETCO2 and
PETO2 returned to baseline levels in the
recovery period. Our laboratory has previously demonstrated close
correspondence in changes in PETCO2 and
arterial PCO2 in humans under conditions in
which the fraction of inspired CO2 and
E
were raised (24). Second, measurements of medullary
surface pH showed a return to baseline levels within 1 min of
termination of CO2 inhalation (2), and
arterial blood gases and carotid sinus nerve activity also returned to
normal within 15 s after apnea termination (7, 15).
Hemodynamic Responses to Intermittent Asphyxia
In the present experiments, the persistent sympathetic activation after asphyxic exposure was not accompanied by an increase in heart rate, even though heart rate oscillated within the asphyxia-interasphyxia cycles and the average heart rate was higher during intermittent asphyxia than in the baseline period. Thus the carryover effect of muscle sympathetic nerve traffic appears to be a unique response to asphyxic exposure that is not reflected in an associated elevation in cardiac sympathetic activity or in an augmentation of
E.
In our study, intermittent asphyxia produced regular arterial pressure fluctuations above and below the baseline level but no sustained increases in systolic or diastolic pressure. Although this minimal effect on arterial pressure seems incongruous with the large increase in sympathetic vasoconstrictor outflow produced by intermittent asphyxia, it is, nevertheless, consistent with data reported by other investigators (12, 18). In humans breathing 8-12% O2, increases in sympathetic outflow to skeletal muscle were not accompanied by increases in plasma norepinephrine concentrations (18). In addition, the local vasodilatory effects of hypoxia and hypercapnia in many vascular beds are well known (8). It is likely that, during the asphyxic exposure, the vasoconstrictor effects of increased muscle sympathetic nerve activity were not able to offset these local vasodilator effects sufficiently to raise peripheral vascular resistance and blood pressure.
Why then was there no increase in arterial pressure in the postasphyxia recovery period when sympathetic activation remained high and the local vasodilatory effects of the asphyxic stimuli had presumably dissipated? The reasons for this dissociation between sympathetic vasomotor outflow and blood pressure are unclear. It is possible that the magnitude of the postasphyxic increase in sympathetic vasoconstrictor outflow to skeletal muscle was not sufficient to sustain the rise in arterial pressure, perhaps because of the offsetting of vasodilation in other vascular beds. It is similarly possible that the asphyxic exposure period was too brief to produce long-lasting cardiovascular effects. It is clear from previous studies in experimental animals (9, 23) and humans (3, 5) that longer term hypoxic exposure (days rather than minutes) does elicit a hypertensive effect that persists after removal of the chemical stimulus.
Our intermittent asphyxia intervention mimicked the oscillations in PO2 and PCO2 typically experienced by patients with sleep apnea syndrome; however, our model differs from this clinical entity in several important ways. The model we used failed to replicate apnea, upper airway obstruction, the sleep state, and arousal from sleep. Thus parallels between our observation of persistent sympathetic activation after intermittent asphyxia and the chronically elevated sympathetic nervous system activity seen in patients with sleep apnea syndrome must be drawn with caution.
In summary, the major finding of this study is that intermittent exposure to asphyxia causes an elevation in muscle sympathetic nerve activity that outlasts the chemical stimuli. Our findings raise the intriguing possibility that sustained sympathetic activation may contribute to the carryover effect on daytime blood pressure after nocturnal intermittent hypoxia (3).
| |
ACKNOWLEDGEMENTS |
|---|
This study was supported by the Medical Research Service of the Department of Veterans Affairs; the National Heart, Lung, and Blood Institute; and the American Heart Association of Wisconsin.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: A. Xie, Pulmonary Physiology Laboratory, William S. Middleton Veterans Hospital, 2500 Overlook Terrace, Madison, WI 53705 (E-mail: axie{at}facstaff.wisc.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 16 July 1999; accepted in final form 6 May 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Abraham, WC.
Metaplasticity: key element in memory and learning?
News Physiol Sci
14:
85,
1999
2.
Ahmad, HR,
and
Loeschcke HH.
Transient and steady state responses of pulmonary ventilation to the medullary extracellular pH after approximately rectangular changes in alveolar PCO2.
Pflügers Arch
395:
285-292,
1982[ISI][Medline].
3.
Arabi, Y,
Morgan BJ,
Goodman B,
Puleo DS,
Xie A,
and
Skatrud JB.
Daytime blood pressure elevation after nocturnal hypoxia.
J Appl Physiol
87:
689-698,
1999
4.
Badr, MS,
Skatrud JB,
and
Dempsey JA.
Determinants of poststimulus potentiation in humans during NREM sleep.
J Appl Physiol
73:
1958-1971,
1992
5.
Bender, PR,
Groves BM,
McCullough RE,
McCulough RG,
Huang SY,
Hamilton AJ,
Wagner PD,
Cymerman A,
and
Reeves JT.
Oxygen transport to exercising leg in chronic hypoxia.
J Appl Physiol
65:
2592-2597,
1988
6.
Carlson, JT,
Hedner J,
Elam M,
Ejnell H,
Sellgren J,
and
Wallin BG.
Augmented resting sympathetic activity in awake patients with obstructive sleep apnea.
Chest
103:
1763-1768,
1993
7.
Chow, CM,
Xi L,
Smith CA,
Saupe KW,
and
Dempsey JA.
A volume-dependent apneic threshold during NREM sleep in the dog.
J Appl Physiol
76:
2315-2325,
1994
8.
Daugherty, RM, Jr,
Scott JB,
Dabney JM,
and
Haddy FJ.
Local effects of O2 and CO2 on limb, renal, and coronary vascular resistances.
Am J Physiol
213:
1102-1110,
1967.
9.
Fletcher, EC,
Lesske J,
Qian W,
Miller CC, III,
and
Unger T.
Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats.
Hypertension
19:
555-561,
1992
10.
Gregor, M,
and
Jänig W.
Effects of systemic hypoxia and hypercapnia on cutaneous and muscle vasoconstrictor neurones to the cat's hindlimb.
Pflügers Arch
368:
71-81,
1977[ISI][Medline].
11.
Hayashi, F,
Coles SK,
Bach KB,
Mitchell GS,
and
McCrimmon DR.
Time-dependent phrenic nerve responses to carotid afferent activation: intact vs. decerebellate rats.
Am J Physiol Regulatory Integrative Comp Physiol
265:
R811-R819,
1993
12.
Hedner, JA,
Wilcox I,
Laks L,
Grunstein RR,
and
Sullivan CE.
A specific and potent pressor effect of hypoxia in patients with sleep apnea.
Am Rev Respir Dis
146:
1240-1245,
1992[ISI][Medline].
13.
Millhorn, DE,
Eldridge FL,
and
Waldrop TG.
Prolonged stimulation of respiration by a new central neural mechanism.
Respir Physiol
41:
87-103,
1980[ISI][Medline].
14.
Morgan, BJ,
Crabtree DC,
Palta M,
and
Skatrud JB.
Combined hypoxia and hypercapnia evokes long-lasting sympathetic activation in humans.
J Appl Physiol
79:
205-213,
1995
15.
O'Donnell, CP,
Schwartz AR,
Smith PL,
Robotham JL,
Fitzgerald RS,
and
Shirahata M.
Reflex stimulation of renal sympathetic nerve activity and blood pressure in response to apnea.
Am J Respir Crit Care Med
154:
1763-1770,
1996[Abstract].
16.
Ponte, J,
and
Purves MJ.
Frequency response of carotid body chemoreceptors in the cat to changes of PaCO2, PaO2, and pHa.
J Appl Physiol
37:
635-647,
1974
17.
Rea, RF,
and
Wallin BG.
Sympathetic nerve activity in arm and leg muscles during lower body negative pressure in humans.
J Appl Physiol
66:
2778-2781,
1989
18.
Rowell, LB,
Johnson DG,
Chase PB,
Comess KA,
and
Seals DR.
Hypoxemia raises muscle sympathetic activity but not norepinephrine in resting humans.
J Appl Physiol
66:
1736-1743,
1989
19.
Somers, VK,
Mark AL,
Zavala DC,
and
Abboud FM.
Influence of ventilation and hypocapnia on sympathetic nerve responses to hypoxia in normal humans.
J Appl Physiol
67:
2095-2100,
1989
20.
Somers, VK,
Mark AL,
Zavala DC,
and
Abboud FM.
Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans.
J Appl Physiol
67:
2101-2106,
1989
21.
Sun, MK,
and
Reis DJ.
Central neural mechanisms mediating excitation of sympathetic neurons by hypoxia.
Prog Neurobiol
44:
197-219,
1994[ISI][Medline].
22.
Vallbo, ÅB,
Hagbarth KE,
Torebjörk HE,
and
Wallin BG.
Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves.
Physiol Rev
59:
919-957,
1979
23.
Vaziri, ND,
and
Wang ZQ.
Sustained systemic arterial hypertension induced by extended hypobaric hypoxia.
Kidney Int
49:
1457-1463,
1996[ISI][Medline].
24.
Wilson, CR,
Satoh M,
Skatrud JB,
and
Dempsey JA.
Non-chemical inhibition of respiratory motor output during mechanical ventilation in sleeping humans.
J Physiol (Lond)
518:
605-618,
1999
25.
Xie, A,
Skatrud JB,
Puleo DS,
and
Morgan BJ.
Arousal from sleep shortens sympathetic burst latency in humans.
J Physiol (Lond)
515:
621-628,
1999
This article has been cited by other articles:
![]() |
Z. Dujic, V. Ivancev, K. Heusser, G. Dzamonja, I. Palada, Z. Valic, J. Tank, A. Obad, D. Bakovic, A. Diedrich, et al. Central chemoreflex sensitivity and sympathetic neural outflow in elite breath-hold divers J Appl Physiol, January 1, 2008; 104(1): 205 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Buyse, J. Hedner, and the participants of working group 2 Sleep apnoea, hypertension and vascular disease: where are we now? Eur. Respir. Rev., December 1, 2007; 16(106): 169 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. A. Leuenberger, C. S. Hogeman, S. Quraishi, L. Linton-Frazier, and K. S. Gray Short-term intermittent hypoxia enhances sympathetic responses to continuous hypoxia in humans J Appl Physiol, September 1, 2007; 103(3): 835 - 842. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Imadojemu, Z. Mawji, A. Kunselman, K. S. Gray, C. S. Hogeman, and U. A. Leuenberger Sympathetic Chemoreflex Responses in Obstructive Sleep Apnea and Effects of Continuous Positive Airway Pressure Therapy Chest, May 1, 2007; 131(5): 1406 - 1413. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Fu, N. E. Townsend, S. M. Shiller, E. R. Martini, K. Okazaki, S. Shibata, M. J. Truijens, F. A. Rodriguez, C. J. Gore, J. Stray-Gundersen, et al. Intermittent hypobaric hypoxia exposure does not cause sustained alterations in autonomic control of blood pressure in young athletes Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2007; 292(5): R1977 - R1984. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Smith and C. F. Pacchia Sleep Apnoea & Hypertension: Physiological bases for a causal relation: Sleep apnoea and hypertension: role of chemoreflexes in humans Exp Physiol, January 1, 2007; 92(1): 45 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Foster, M. J. Poulin, and P. J. Hanly Sleep Apnoea & Hypertension: Physiological bases for a causal relation: Intermittent hypoxia and vascular function: implications for obstructive sleep apnoea Exp Physiol, January 1, 2007; 92(1): 51 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-J. C. Lusina, P. M. Kennedy, J. T. Inglis, D. C. McKenzie, N. T. Ayas, and A. W. Sheel Long-term intermittent hypoxia increases sympathetic activity and chemosensitivity during acute hypoxia in humans J. Physiol., September 15, 2006; 575(3): 961 - 970. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L Cooper, S. B Pearson, C. M Bowker, M. W Elliott, and R Hainsworth Interaction of chemoreceptor and baroreceptor reflexes by hypoxia and hypercapnia - a mechanism for promoting hypertension in obstructive sleep apnoea J. Physiol., October 15, 2005; 568(2): 677 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Tamisier, A. Anand, L. M. Nieto, D. Cunnington, and J. W. Weiss Arterial pressure and muscle sympathetic nerve activity are increased after two hours of sustained but not cyclic hypoxia in healthy humans J Appl Physiol, January 1, 2005; 98(1): 343 - 349. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Cutler, N. M. Swift, D. M. Keller, W. L. Wasmund, J. R. Burk, and M. L. Smith Periods of intermittent hypoxic apnea can alter chemoreflex control of sympathetic nerve activity in humans Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2054 - H2060. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. N. Ainslie and M. J. Poulin Ventilatory, cerebrovascular, and cardiovascular interactions in acute hypoxia: regulation by carbon dioxide J Appl Physiol, July 1, 2004; 97(1): 149 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Tamisier, D. Norman, A. Anand, Y. Choi, and J. W. Weiss Evidence of sustained forearm vasodilatation after brief isocapnic hypoxia J Appl Physiol, May 1, 2004; 96(5): 1782 - 1787. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Cutler, N. M. Swift, D. M. Keller, W. L. Wasmund, and M. L. Smith Hypoxia-mediated prolonged elevation of sympathetic nerve activity after periods of intermittent hypoxic apnea J Appl Physiol, February 1, 2004; 96(2): 754 - 761. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. M. Ip, H.-F. Tse, B. Lam, K. W. T. Tsang, and W.-K. Lam Endothelial Function in Obstructive Sleep Apnea and Response to Treatment Am. J. Respir. Crit. Care Med., February 1, 2004; 169(3): 348 - 353. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Marrone, A. Salvaggio, M.R. Bonsignore, G. Insalaco, and G. Bonsignore Blood pressure responsiveness to obstructive events during sleep after chronic CPAP Eur. Respir. J., March 1, 2003; 21(3): 509 - 514. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. T. LEUNG and T. DOUGLAS BRADLEY Sleep Apnea and Cardiovascular Disease Am. J. Respir. Crit. Care Med., December 15, 2001; 164(12): 2147 - 2165. [Full Text] [PDF] |
||||
![]() |
A. Xie, J. B. Skatrud, D. S. Puleo, and B. J. Morgan Exposure to hypoxia produces long-lasting sympathetic activation in humans J Appl Physiol, October 1, 2001; 91(4): 1555 - 1562. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |